We are live on ! Find out more
IART icon

Integra LifeSciences

251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

40% more capital invested

Capital invested by funds: $3.43B → $4.8B (+$1.38B)

6% more funds holding

Funds holding: 237251 (+14)

1.68% more ownership

Funds ownership: 86.29%87.97% (+1.7%)

10% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 92

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

37% less call options, than puts

Call options by funds: $2.61M | Put options by funds: $4.13M

Holders
251
Holders Change
+14
Holders Change %
+5.91%
% of All Funds
4.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
83
Reduced
92
Closed
15
Calls
$2.61M
Puts
$4.13M
Net Calls
-$1.52M
Net Calls Change
-$1.86M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
26
Invesco
Georgia
$32.9M -$4.42M -82,136 -14%
HRCM
27
Hood River Capital Management
Florida
$31.3M +$446K +8,282 +2%
Morgan Stanley
28
Morgan Stanley
New York
$30.8M +$4.27M +79,336 +20%
Citigroup
29
Citigroup
New York
$27.5M -$993K -18,449 -4%
Jennison Associates
30
Jennison Associates
New York
$26.4M +$2.6M +48,322 +14%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$22.2M -$15.7M -292,627 -46%
Bank of America
32
Bank of America
North Carolina
$20.6M -$2.24M -41,710 -12%
Fuller & Thaler Asset Management
33
Fuller & Thaler Asset Management
California
$18.5M +$11.1M +206,260 +263%
EAM
34
Eagle Asset Management
Florida
$17.8M -$4.02M -74,702 -21%
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$17M -$2.27M -42,211 -14%
SI
36
Sapience Investments
California
$16.1M -$984K -18,280 -7%
PPA
37
Parametric Portfolio Associates
Washington
$15.8M +$858K +15,945 +7%
Principal Financial Group
38
Principal Financial Group
Iowa
$13.6M -$16.3K -303 -0.1%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$13.5M +$98K +1,822 +0.9%
AQR Capital Management
40
AQR Capital Management
Connecticut
$13.5M -$2.81M -52,248 -20%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$13.2M -$6.96M -129,294 -39%
Capital International Investors
42
Capital International Investors
California
$12.5M
Legal & General Group
43
Legal & General Group
United Kingdom
$12.3M -$94.2K -1,750 -0.9%
SBH
44
Segall Bryant & Hamill
Illinois
$11.9M +$744K +13,831 +8%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$11.6M +$881K +16,372 +10%
FWIA
46
Fort Washington Investment Advisors
Ohio
$11.2M -$254K -4,725 -3%
Swiss National Bank
47
Swiss National Bank
Switzerland
$10.5M -$80.7K -1,500 -0.9%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$10.2M -$1.01M -18,680 -11%
SEI Investments
49
SEI Investments
Pennsylvania
$9.43M +$292K +5,427 +4%
TRSOTSOK
50
Teachers Retirement System of the State of Kentucky
Kentucky
$9.35M +$2.08M +38,631 +37%

IART Hedge Fund Activity: Q4 2020 in Review

251 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2020, worth a combined $4.8B — up 40% from $3.43B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IART positions and 15 closed out — a net gain of 16 holders — while 83 added to existing stakes and 92 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.6M. The largest seller was Capital Research Global Investors, cutting an estimated $38.9M.

  • 251 institutional investors held Integra LifeSciences (IART) as of Q4 2020, up from 237 in Q3 2020.
  • Funds reported $4.8B of Integra LifeSciences stock for Q4 2020, up 40% quarter-over-quarter.
  • 31 funds opened new Integra LifeSciences positions in Q4 2020 and 15 closed out, a net change of +16 holders.
  • The largest Integra LifeSciences buyer in Q4 2020 was Wellington Management Group, an estimated $77.6M added.
  • The largest Integra LifeSciences seller in Q4 2020 was Capital Research Global Investors, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2020.